Tuesday, 28 September 2021

 

 

LATEST NEWS Union Minister of State Tribal Affairs Renuka Singh visits District Kulgam Union MoS Road Transport and Highways, Civil Aviation Dr. V. K. Singh visits Anantnag Union MoS, Tribal Affairs Renuka Singh interacts with DDC, BDC members, other PRI representatives at Kulgam Union Minister of State for Finance inaugurates various development projects in Jammu Union MoS Jal Shakti, Tribal Affairs, Bishweswar Tudu concludes visit to Kishtwar Lt Governor visits “The Paradise Fest” organized to celebrate World Tourism Week Charanjit Singh Channi Asks Administrative Secretaries To Prepare 100 Days Roadmap To Ensure Holistic Development Of State Charanjit Singh Channi Calls Emergency Meeting On Farmers' Issues In Wake Of 'Bharat Bandh' Call Given By Samyukt Kisan Morcha Charanjit Singh Channi Curtails Security Of VVIPs SSP Pulwama Gulam Jeelani Wani, assume charge, held introductory meeting with Visits various posts of district police Pulwama Parliamentarian Delegation arriving to interact with common people in Kashmir Assam's highest civilian award for national integration to be conferred by V-P Naidu RSS statement on Amazon irrelevant : Randeep Singh Surjewala India-US enhanced ties to boost research, health management : Bharati Pravin Pawar Shafali Verma and Radha Yadav sign up for Sydney Sixers in WBBL England cricketer Moeen Ali retires from Test cricket Don't see that aggressiveness in this Mumbai Indians side : Zaheer Khan Why India needs to rediscover Armenia to counter Turkey and Pakistan Shanaya Kapoor joins Ritu Kumar's squad 'Do you think you are Mother Teresa?' Afghan airline flies out relatives, staff impersonating journos

 

Johnson & Johnson Covid-19 vaccine benefits 'far outweigh' risks: CDC

Coronavirus, COVID 19, Covaxin, Covishield, Covid-19 Vaccine, Sputnik V, Pfizer, Astra Zeneca, Remdesivir, Covifor, Johnson & Johnson Covid-19 vaccine, Centers for Disease Control and Prevention, CDC, Food and Drug Administration, Delta Plus Covid variant, Delta Covid-19 variant

Web Admin

Web Admin

5 Dariya News

Washington , 23 Jul 2021

The benefits of the Johnson & Johnson Covid-19 vaccine far outweigh its potential risks amid an ongoing review of reports of a rare neurological disorder, according to an advisory panel to the US Centers for Disease Control and Prevention (CDC) on Thursday.There have been 8.1 cases of Guillain-Barre syndrome per 1 million doses, which is higher than expected in the general population and close to eight times the rate seen in Pfizer's and Moderna's shots, according to data presented at a meeting of CDC's Advisory Committee on Immunization Practices on Thursday.Guillain-Barre is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, according to the US Food and Drug Administration (FDA).The data came after the US Food and Drug Administration (FDA) announced a new warning on July 12 for the Johnson & Johnson shot after preliminary reports of Guillain-Barre syndrome in some recipients, the Xinhua news agency reported.About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the US, according to the FDA.Of these reported cases, 95 were serious and required hospitalisation, and one was dead.

 

Tags: Coronavirus , COVID 19 , Covaxin , Covishield , Covid-19 Vaccine , Sputnik V , Pfizer , Astra Zeneca , Remdesivir , Covifor , Johnson & Johnson Covid-19 vaccine , Centers for Disease Control and Prevention , CDC , Food and Drug Administration , Delta Plus Covid variant , Delta Covid-19 variant

 

 

related news

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD